Atopic Dermatitis and Eczema
Conditions
Interventions
Sponsors
The First Center Hospital of Tianjin
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Aged > 12 years, regardless of gender; 2.According to the judgment of the researcher, it is suitable for mild to moderate atopic dermatitis patients treated with Benvimod cream (3% <= lesion area <= 20%); Or patients who cannot be definitely diagnosed as atopic dermatitis, but meet the clinical manifestations of eczema and need to be treated according to eczema; 3.Women who are not pregnant and do not plan to become pregnant during the trial; 4.Fully understand the test content, voluntarily participate in the test, and have signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Pregnancy, breastfeeding women, or by women during pregnancy; 2. known to be allergic to the research activity of drug components or accessories; 3. you may be other reasons to complete the study in patients with, or researchers do not consider it appropriate to this researcher.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Eczema Area and Severity Index (EASI); | — |
Secondary
| Measure | Time frame |
|---|---|
| Body surface lesion area (BSA);Visual Analogu Scale (VAS);Dermatology Life Quality Index (DLQI); | — |
Countries
China
Contacts
Public ContactJi Liming
The First Center Hospital of Tianjin
Outcome results
None listed